Clinical Trial Update: [18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib [NA]

View source ↗

Summary

A completed clinical trial evaluated whether [18F]FLT-PET imaging can predict responses to regorafenib in colorectal cancer, with results posted in October 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Asan Medical Center | Conditions: Colorectal Cancer | NA | Status: COMPLETED | Results posted: 2024-10-04